Childhood cancers trials in France

In France 205 Also abroad 2478

205 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
AQUALIS:QoL of CLL Patients Treated With Acalabrutinib in France, Retrospective Study Based on Data From PLATON Database
Where
Saint-Affrique
People
120
Run by
AstraZeneca
See details and how to joinNCT06548152
No phaseTaking people
Menin Inhibitors in Pediatric Relapsed or Refractory Acute Leukemia
Where
Strasbourg
Age
0 years to 17 years
People
10
Run by
University Hospital, Strasbourg, France
See details and how to joinNCT07898436
Phase 3Taking people
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
Where
Amiens, ANGERS Cedex 09, Besancon Cedex, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, Grenoble cedex 09, Lille, Limoges, Lyon, Marseille, Montpellier Cedex 05, Nantes, Nice, Paris, Poitiers, Reims, Rennes, Rouen, Saint-Etienne, Strasbourg Cedex 2, Toulouse, Tours, Vanoeuvre les Nancy
Age
1 year to 64 years
People
750 worldwide
Run by
Charite University, Berlin, Germany
See details and how to joinNCT07476729 · EU 2023-509392-17-00
Phase 3Taking people
Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
Where
Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Dijon, Grenoble, La Réunion, Lille, Limoges, Lyon, Marseille, Montpellier, Nantes, Nice, Paris, Poitiers, Reims, Rennes, Rouen, Saint-Etienne, Saint-Herblain, Strasbourg, Toulouse, Tours, Vandœuvre-lès-Nancy, Villejuif
Age
4 years and over
People
530 worldwide
Run by
Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07871864
No phaseTaking people
Characterization of CD180 Protein Expression in Myeloid Hematological Malignancies by Flow Cytometry
Where
Strasbourg
Age
1 year and over
People
50
Run by
University Hospital, Strasbourg, France
See details and how to joinNCT07895901
No phaseTaking people
Registry of Endocrine Tumors (Thyroid, Parathyroid, Adrenal, Endocrine Pancreas, Endocrine Digestive Tube)
Where
Vandœuvre-lès-Nancy
People
3,000
Run by
Central Hospital, Nancy, France
See details and how to joinNCT03410394
Phase 3Taking people
International study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastine
Where
Amiens Cedex 1, Angers, Besancon Cedex, Bordeaux, Brest, Caen Cedex 9, Clermont-Ferrand, Dijon, Grenoble Cedex 9, Lille Cedex, Lyon, Marseille, Montpellier Cedex 5, Nantes, Nice, Paris, Poitiers, Reims, Rennes, Rouen Cedex, Saint-Denis, St Etienne Cedex 2, Strasbourg Cedex 2, Toulouse Cedex 9, Tours, Vandoeuvre Les Nancy, Villejuif
Age
Up to 17 years
People
137 worldwide
Run by
GPOH gGmbH
See details and how to join2022-501454-11-00
Phase 3Taking people
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0
Where
Amiens Cedex 1, Angers, Besançon, Bobigny, Bordeaux, Bordeaux Cedex, Brest, Bron, Caen, Caen Cedex 5, Clermont-Ferrand, Clichy, Dijon, Grenoble Cedex 9, La Réunion., La Tronche, Le Kremlin Bicetre Cedex, Lille, Limoges, Lyon, Marseille, Metz Cedex 03, Montpellier, Montpellier Cedex 5, Nancy, Nice, NICE, Nice Cedex 2, Paris, Pessac, Poitiers, Reims Cedex, Rennes, Rennes Cedex, Rouen Cedex, Saint-Denis, Saint-Herblain Cedex, Saint-Pierre, Saint-Pierre Cedex, Saint-Priest-en-Jarez, STRASBOURG, Alsace, Strasbourg Cedex 2, Suresnes, Toulouse, Toulouse Cedex 9, Tours, Vandoeuvre Les Nancy, Vandouvre Les Nancy, Villejuif
Age
6 months and over
People
433 worldwide
Run by
Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT05476939 · EU 2023-506027-29-00
Phase 3Taking people
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Where
Amiens Cedex 1, Angers, Bayonne, Caen Cedex 9, Le Chesnay Rocquencourt, Le Mans, Lille Cedex, Limoges Cedex 1, Marseille, Nice, Paris, Pessac, Pierre-Bénite, Rouen Cedex, Strasbourg Cedex 2
Age
12 years and over
People
468 worldwide
Run by
Syndax Pharmaceuticals
See details and how to joinNCT07211958 · EU 2025-522279-27-00
Phase 3Not yet taking people in France
Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma
Where
Villejuif
Age
Up to 5 years
People
96 worldwide
Run by
Nationwide Children's Hospital
See details and how to joinNCT07291102 · EU 2024-517133-40-00
Phase 2/3Taking people
Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL
Where
Paris
Age
3 months to 25 years
People
1,000 worldwide
Run by
Bambino Gesù Hospital and Research Institute
See details and how to joinNCT07297914 · EU 2025-522052-13-00
Phase 3Taking people
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Where
Lille, Paris, Pessac
People
115 worldwide
Run by
Pierre Fabre Medicament
See details and how to joinNCT03394365 · EU 2024-516622-57-00
Phase 3Taking people
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Where
Amiens Cedex 1, Besancon Cedex, Bordeaux, Grenoble Cedex 9, Lille Cedex, Lyon, Marseille, Montpellier, Nantes, Nice, Paris, Poitiers, Reims, Rennes, Rouen Cedex, St Etienne Cedex 2, Strasbourg Cedex 2, Toulouse Cedex 9, Vandoeuvre Les Nancy
Age
1 day to 1 year
People
160 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05327894 · EU 2022-502503-30-00
Phase 2Taking people
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
Where
Lille, Lyon, Marseille, Strasbourg Cedex 2
Age
Up to 19 years
People
232 worldwide
Run by
Medical University of Vienna
See details and how to joinNCT01356290 · EU 2024-515626-92-00
Phase 1/2Taking people
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Where
Caen, Marseille, Nantes, Paris, Pierre-Bénite, Toulouse Cedex 9
Age
12 years and over
People
255 worldwide
Run by
AstraZeneca
See details and how to joinNCT06137118 · EU 2023-505840-20-00
Phase 1/2Taking people
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Where
Créteil, Dijon, Lille, Pierre-Bénite, Villejuif
Age
12 years and over
People
161 worldwide
Run by
AstraZeneca
See details and how to joinNCT06137144 · EU 2023-506747-42-00
Phase 1/2Taking people
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Where
Paris, Poitiers, Rennes
Age
1 year to 17 years
People
70 worldwide
Run by
Incyte Biosciences International Sàrl
See details and how to joinNCT03934372 · EU 2023-509699-41-00
Phase 1/2Taking people
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Where
Paris, Pessac, Pierre-Bénite, Villejuif
Age
30 days and over
People
447 worldwide
Run by
Syndax Pharmaceuticals
See details and how to joinNCT04065399 · EU 2024-513759-34-00
Phase 1Taking people
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Where
Pierre-Bénite
Age
15 years and over
People
282 worldwide
Run by
Xencor, Inc.
See details and how to joinNCT06276491
Phase 1Taking people
Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia
Where
Nantes, Paris
Age
0 years to 21 years
People
20 worldwide
Run by
PedAL BCU, LLC
See details and how to joinNCT06376162 · EU 2023-505262-28-00
Phase 1/2Not yet taking people in France
Study of the safety and efficacy of asciminib in pediatric and young adult participants with r/r Ph+ or ABL-class Ph-like ALL
Where
Bordeaux, Lyon, Marseille, Nantes, Paris, Pessac, Rennes Cedex 9
Age
Up to 64 years
People
22 worldwide
Run by
Novartis Pharma AG
See details and how to join2025-522019-40-00
Phase 2/3Taking people
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Where
Bayonne, Bordeaux, Boulogne-Billancourt, Grenoble Cedex 9, Lille, Marseille, Nice, Paris Cedex 18, Pierre-Bénite, Rouen Cedex, Saint-Herblain Cedex, Strasbourg
Age
18 years and over
People
740 worldwide
Run by
Eikon Therapeutics
See details and how to joinNCT06697301 · EU 2024-512659-19-00
Phase 1/2Taking people
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
Where
Bordeaux, Lyon, Marseille, Nantes, Paris, Villejuif
Age
1 month to 17 years
People
50 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06941272 · EU 2024-518771-66-00
Phase 1Taking people
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Where
Bordeaux, Paris
Age
6 months to 17 years
People
18 worldwide
Run by
AbbVie
See details and how to joinNCT07306832
Phase 1/2Taking people
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Where
Bordeaux, Clermont-Ferrand, Lyon, Nîmes, Saint-Herblain, Strasbourg, Toulouse, Vandœuvre-lès-Nancy, Villejuif
Age
12 years and over
People
300 worldwide
Run by
PMV Pharmaceuticals, Inc
See details and how to joinNCT04585750